Life After GLP-1: New nference RWE Study Challenges Clinical Trial Assumptions on Weight Regain (Featured in Reuters)

Study of heart diseases, including diagnosis, treatment, and prevention of cardiovascular disorders.

Vector (6).svg

Cardio.mp4

Frame 1244832934 (1).svg

Frame 1244832932 (1).png

Frame 1244832931 (1).svg

Frame 1244833057.png

Frame 1244832933 (1).svg

Approximately 48% of Americans over 20 are affected by cardiovascular diseases. Our Real world evidence platform supports research that enhances clinical data analysis to improve patient outcomes.

Study of the immune system, its functions, disorders, and role in disease defense.

Group 1244832696 (1).svg

Immunology.mp4

As the recent pandemic has shown, immunological breakthroughs can help save millions of lives. Our data and technology enable leading-edge immunology clinical trials leading to drug efficacy.

Conditions affecting a small percentage of the population, often genetic and challenging to diagnose.

Group (5).svg

Rare (1).mp4

300 million people worldwide are affected by over 7000 known rare diseases, with 72% of them being genetic. Our novel molecular data helps to find genomic changes.

Branch of medicine focused on the diagnosis, treatment, and research of cancer.

Group (4).svg

Oncology.mp4

As cancer cases are projected to surpass 35 million by 2025, oncology research is paramount. Our data empowers researchers to expedite the discovery and development of effective cancer therapies.

Medical specialty concerned with kidney function, diseases, and treatment, including dialysis and transplantation.

Group (6).svg

nephrology.mp4

850 million people worldwide are estimated to have kidney diseases. Using our real-world data, researchers can improve diagnosis, potentially preventing acute cases from progressing into chronic ones.

Study of diseases caused by pathogens, including bacteria, viruses, fungi, and parasites.

Group 1244832698 (2).svg

Infectious.mp4

Around 1 billion individuals worldwide are affected by various infectious diseases. We aid scientists to combat these diseases by developing effective prevention and treatment strategies

Medical specialty dealing with disorders of the nervous system, including the brain and spinal cord.

Vector (4).svg

Neurology.mp4

Over 3 billion people worldwide suffer from neurological conditions. Our mission is to support the development of newer, more effective therapies.

Branch of medicine focused on the study, diagnosis, and treatment of disorders related to the digestive system, including the stomach, intestines, liver, pancreas, and gallbladder.

Layer_x0020_1.svg

Unlock actionable insights to improve patient outcomes and optimize healthcare delivery with data-driven solutions.

For Health Systems

With our partners - industry leaders, innovators and leading institutions - we’re delivering real-world data insights and shaping transformative solutions in healthcare.  

Harness diverse real-world data types to gain insights across genomic, clinical, and operational dimensions

Data Modality

Deeply integrated gene panel and whole exome sequencing data powered with Agentic AI Solutions

Patient-Consented Biobank

nference’s platform and tools transform real world data into actionable insights for healthcare innovation.

Join global leaders and pioneers to explore how agentic intelligence is redefining the era of precision medicine, driving breakthroughs by decoding the many diverse languages of biology, and powering every other major industry in ways befitting this 'Age of AI'.

Join our upcoming events to explore the latest industry trends, discover technological breakthroughs, and gain expert insights. Network with leaders and stay at the forefront of healthcare innovation.

Streamline research with AI-powered tools that transform complex data into actionable medical insights

For Clinical Researchers

Access advanced datasets and cutting-edge analytics to power innovation in healthcare and life sciences.

For Data Scientists

nSights turns complex healthcare data into actionable insights, driving innovation and smarter decision-making in medical research and development.

Revolutionize drug development through AI-driven insights, accelerating timelines and improving clinical trial outcomes.

For Bio Pharma

Empower device innovation with robust data integration and advanced analytics for regulatory and market success.

Medical Devices

Our AI-driven solutions empower clinical trial design, enhance innovation in product development and streamline regulatory submissions.

GLP-1 receptor agonists (GLP-1RAs) such as semaglutide and tirzepatide have transformed obesity care and weight management, delivering unprecedented levels of weight loss in real-world practice.

What happens to weight after we stop prescribing GLP-1 therapies?

Characterization of Patients With Narcolepsy Treated vs Not Treated With Sodium Oxybate: A Propensity Score–Matched Cohort Study

Associations of the Fibrosis-4 Index With Rates of Cardiac Events and Liver Decompensation, and the Potential Implications on Risk Stratification in Patients With Nonalcoholic Steatohepatitis.

nference's extensive library of publications showcase cutting-edge research and healthcare advancements.

Blogs

nference Establishes AI Initiative with Takeda to Advance Precision Medicine in Inflammatory Bowel Disease

News

Our latest blogs and insights cover industry trends, technological breakthroughs, and expert insights, to keep you updated on the forefront of healthcare innovation.

Cutting-edge AI solutions to transform cardiac care

Empowering digital pathology with a new WSI paradigm